119 related articles for article (PubMed ID: 19657726)
1. Decreased p21 expression in HPV-18 positive cervical carcinomas.
Huang LW; Seow KM; Lee CC; Lin YH; Pan HS; Chen HJ
Pathol Oncol Res; 2010 Mar; 16(1):81-6. PubMed ID: 19657726
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
Milde-Langosch K; Riethdorf S; Kraus-Pöppinghaus A; Riethdorf L; Löning T
Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
[TBL] [Abstract][Full Text] [Related]
3. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
Liu JH; Huang H; Huang X; Zeng MS; Li W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523
[TBL] [Abstract][Full Text] [Related]
4. The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer.
Li W; Thompson CH; Cossart YE; O'Brien CJ; Liu J; Scolyer RA; Carter JR; Dalrymple C; Rose BR
Mod Pathol; 2004 Sep; 17(9):1031-7. PubMed ID: 15143339
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
[TBL] [Abstract][Full Text] [Related]
6. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
[TBL] [Abstract][Full Text] [Related]
7. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
Helland A; Karlsen F; Due EU; Holm R; Kristensen G; Børresen-Dale Al
Br J Cancer; 1998 Jul; 78(1):69-72. PubMed ID: 9662253
[TBL] [Abstract][Full Text] [Related]
9. Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.
Devor EJ; Reyes HD; Gonzalez-Bosquet J; Warrier A; Kenzie SA; Ibik NV; Miller MD; Schickling BM; Goodheart MJ; Thiel KW; Leslie KK
Int J Gynecol Cancer; 2017 May; 27(4):784-790. PubMed ID: 28375929
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of CDK inhibitors and p53 in HPV-negative endocervical adenocarcinoma.
Omori M; Hashi A; Kondo T; Katoh R; Hirata S
Int J Gynecol Pathol; 2015 Mar; 34(2):196-203. PubMed ID: 25675191
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
Horikoshi M; Kina K; Ishi K; Izumi H; Kunii Y; Nojima M
Rinsho Byori; 2005 Jun; 53(6):494-8. PubMed ID: 16026074
[TBL] [Abstract][Full Text] [Related]
12. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
[TBL] [Abstract][Full Text] [Related]
13. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
Shin MK; Balsitis S; Brake T; Lambert PF
Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
Portari EA; Russomano FB; de Camargo MJ; Machado Gayer CR; da Rocha Guillobel HC; Santos-Rebouças CB; Brito Macedo JM
Int J Gynecol Pathol; 2013 Sep; 32(5):501-8. PubMed ID: 23896712
[TBL] [Abstract][Full Text] [Related]
17. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
18. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
19. HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
Senapati R; Nayak B; Kar SK; Dwibedi B
PLoS One; 2017; 12(11):e0187844. PubMed ID: 29161285
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
